7 results
Stroke and bleeding risk stratification with the CHADS2-VASc and HAS-BLED schemas

#Diagnosis #Hematology #CHADS2 #CHADS2VASc #HASBLED #Comparison
Stroke and bleeding risk ... HAS-BLED schemas #Diagnosis ... #Hematology #CHADS2 ... Stroke #Bleed #Anticoagulation ... #AFib
CHA2DS2VASc vs HAS-BLED scores for stroke risk and bleed risk on anticoagulation

C	Congestive Heart Failure	1

H	Hypertension	1

A2	Age >75	2

D	Diabetes Mellitus	1

S2	Stroke,
on anticoagulation ... drinks/week) 1 #CHADS2 ... Stroke #Bleed #Anticoagulation ... #AFib #Diagnosis ... #Hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... patients at high risk ... also balance the risk ... #Anticoagulation ... #Management #Hematology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
Patient risk stratification ... algorithm for the ... treatment of cancer-associated ... #Anticoagulation ... #Management #Hematology
Chronic Hepatitis B - Diagnosis and Management Algorithm

• Who to treat: Essentially treat the pts with
and Management ... Algorithm • Who ... is absent the risk ... #Diagnosis #Management ... #Treatment #Hepatology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Thromboembolism Treatment ... Algorithm Treat ... Thromboembolism #Treatment ... #Algorithm #management ... #hematology #anticoagulation
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
Treatment algorithms ... appropriate only for low risk ... patients with no CV risk ... Hydroxyurea + anticoagulation ... #diagnosis #management